BMCM
CME icon

Bryn Mawr Capital Management’s CME Group CME Stock Holding History

Bryn Mawr Capital Management’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7M Buy
48,505
+139
+0.3% +$38.5K 0.47% 56
2026
Q1 		$14.3M Sell
48,366
-1,277
-3% -$379K 0.69% 37
2025
Q4 		$13.6M Buy
49,643
+837
+2% +$227K 0.65% 39
2025
Q3 		$13.2M Sell
48,806
-75
-0.2% -$20.4K 0.65% 37
2025
Q2 		$13.5M Buy
48,881
+1,266
+3% +$344K 0.74% 30
2025
Q1 		$12.6M Buy
47,615
+7,239
+18% +$1.79M 0.76% 33
2024
Q4 		$9.38M Sell
40,376
-1,618
-4% -$372K 0.51% 53
2024
Q3 		$9.27M Sell
41,994
-13,393
-24% -$2.77M 0.5% 54
2024
Q2 		$10.9M Sell
55,387
-28,454
-34% -$5.88M 0.6% 43
2024
Q1 		$11.5M Buy
83,841
+80,993
+2,844% +$17M 0.65% 41
2023
Q4 		$600K Buy
2,848
+176
+7% +$37.6K 0.04% 262
2023
Q3 		$535K Buy
2,672
+904
+51% +$180K 0.04% 270
2023
Q2 		$328K Buy
+1,768
New +$327K 0.03% 239
2022
Q3 		– Sell
-1,028
Closed -$210K – 145
2022
Q2 		$210K Buy
1,028
+1
+0.1% +$212 0.07% 143
2022
Q1 		$244K Buy
+1,027
New +$241K 0.07% 142

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Bryn Mawr Capital Management's CME Position: Q2 2026 in Review

Bryn Mawr Capital Management increased its CME Group (CME) stake by 0.29% in Q2 2026, buying an estimated $38.5K and bringing the position to 48,505 shares worth $10.7M. The position accounts for 0.47% of the portfolio, ranked #56.

Bryn Mawr Capital Management first reported a position in CME in Q1 2022 and has held it in 15 quarters since. The position peaked at $14.3M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Bryn Mawr Capital Management held 48,505 shares of CME Group worth $10.7M as of Q2 2026.
  • Bryn Mawr Capital Management bought 139 CME Group shares in Q2 2026, an estimated $38.5K.
  • CME Group made up 0.47% of Bryn Mawr Capital Management's portfolio in Q2 2026, its #56 holding.
  • Bryn Mawr Capital Management first reported a position in CME Group in Q1 2022 and has held it in 15 quarters since.
  • Bryn Mawr Capital Management's CME Group position peaked at $14.3M in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.